Osteoporosis, the most serious metabolic bone disease affecting postmenopausal women and elderly men, results in hip and vertebral fracture.
Osteoporosis, the most serious metabolic bone disease affecting postmenopausal women and elderly men, results in hip and vertebral fracture. 1) With the rapid aging of the population worldwide, it is estimated that one of two women and one of eight men over the age of 50 years will have an osteoporotic fracture.
2) Hormonal replacement therapy (HRT) theoretically should be the best choice for the prevention and treatment of postmenopausal osteoporosis.
3) Unfortunately, however, the side effects of HRT often cause patients to discontinue it, especially Asian women. 4) Thus nonhormonal or alternative therapy may be more acceptable for the prevention and treatment of osteoporosis.
Trionyx sinensis WIEGMANN is a freshwater soft-shell turtle (SST) widely cultured in southern China, Japan, Korea, and southeast Asia. 5) The turtle is considered to be an emblem of strength, longevity, and endurance and has been used in medicinal cuisine and as an energizer in tonics in China, Japan, and Korea since ancient times. 6, 7) Regarding its inclusion in Chinese medicine, Anderson commented that animals with a tenacious hold on life or with unusual appearance and behavior are regarded as having special powers. 8) Analysis of T. sinensis indicates that it is a good source of protein, collagen, minerals including calcium and phosphorus, 20 amino acids, 11 unsaturated fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and vitamins A, B 1 , B 2 and D (Table 1) . Previous research on the prevention of osteoporosis revealed that healthy nutrition in childhood can promote the development of peak bone mass, which is important in preventing osteoporosis and bone loss in old age. 9) Due to its nutritional content, SST is effective in the treatment of back pain, hypertension, diabetes, allergy, and asthma. 10) Although the antiosteoporotic activity of SST shell was reported previously, 11) the effects of the powdered whole body were studied by us for the first time. Furthermore, previous studies on the shell involved a short treatment time and used the dual X-ray absorber (DXA) method, which only yields information on bone mineral content (BMC) without differenciation between cortical and cancellous bones. In our research, we used a treatment time of 6 months and the bones were examined with peripheral quantitative computed tomography (pQCT) which yields separate data on cortical and cancellous bones and can measure BMC, bone mineral density (BMD), and bone strength in three directions.
Astaxanthin (3,3Ј-dihydroxy-b,b-carotene-4,4Ј-dione), the main carotenoid pigment of the unicellular green microalga Haematococcus pluvialis (OHP), has strong antioxidative activity against superoxide anion radicals, which are related to estradiol levels in the serum of postmenopausal women. 12) To elucidate the action of SST and the synergistic effects of SST and OHP on bone, SST and a mixture of SST and OHP were The effects of soft-shell turtle (Trionyx sinensis) powder (SST) on the proximal tibiae of ovariectomized (OVX) rats were investigated using peripheral quantitative computed tomography (pQCT) and examination of serum biochemical markers. Considering the relationship between the antioxidative property and antiosteoporotic activity, the synergistic effects of a mixture of SST and essential oil of the microalgae Haematococcus pluvialis (OHP) with strong antioxidant activity were also examined. Oral administration of SST (100, 200 mg/kg) or a mixture of SST (100, 200 mg/kg) and OHP (13, 26 mg/kg) three times weekly prevented the decrease in bone mineral content (BMC) in total bone, BMC and bone mineral density (BMD) in cortical bone, and bone strength indices induced by ovariectomy in a dose-dependent manner without uterine side effects. However, OHP alone showed no significant effects.
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MATERIALS AND METHODS
General Aged female rats (Wistar) were purchased from Sankyo Labo Service (Tokyo, Japan). Cultured SST powder (less than 200 mesh) and essential oil of OHP were provided by Iwatani International Corporation (Tokyo, Japan) and the content of astaxanthin in the essential oil was also determined by Iwatani International Corporation. All other reagents were from Wako Pure Chemical Industries, Ltd. (Japan).
Treatment of Rats The aged female Wistar rats (8 months, 260-330 g) were maintained on a 12-h light/dark cycle in a temperature-and humidity-controlled room. The animals were allowed free access to laboratory pellet chow (CE-2; CLEA Japan Inc., Tokyo, Japan) and water ad libitum during the experiment. After 7 d of acclimatization, all animals were anesthetized with pentobarbital (40 mg/kg i.p.), and both ovaries of all animals, except those in sham-operated groups, were ligated and removed. Sham operation was performed by only exposing the ovaries. Two weeks after surgery, except in the OVX control and sham-operated groups, the four groups of rats were assigned 100 and 200 mg/kg of SST supplement (SST1 and SST2, respectively), 100 mg/kg of SST and 13 mg/kg of OHP supplement (SST1/OHP1), and 200 mg/kg of SST and 26 mg/kg of OHP supplement (SST2/OHP2), which were given orally three times weekly for 6 months in the baseline diet. All samples were suspended in a 1% water solution of carboxymethyl cellulose sodium salt. As positive controls, another group of rats received 17b-estradiol (E 2 ) 0.1 mg/kg dissolved in a mixture of 5% benzyl alcohol and 95% corn oil by intraperitoneal injection. Animals in the sham and OVX control groups were given a 1% water solution of carboxymethyl cellulose sodium salt. The body weight of rats was determined every month. At the end of the experiment, the left tibiae of all rats were scanned with pQCT. At autopsy, blood was collected from the cardioaortic vein under anesthesia and serum samples were stored at less than Ϫ70°C. Then the uteri were removed and weighed.
pQCT Analysis The left tibiae of rats were scanned with pQCT system XCT Research M (Started Medizintechnik GmbH, Germany). The voxel size was 0.08 mm, slice thickness 0.5 mm, and cortical threshold 464 mg/cm 3 . We used the measuring mode for dividing total bone into cortical bone or cancellous bone in peel mode 20. This mode can detect the inner threshold automatically. After a scout scan was obtained and the growth plate was identified, transverse image sets of four cross-sectional slices comprising 1-5 mm of the left proximal tibia below the proximal separation point between the femora and tibia. In each transverse image, BMC, BMD, and area in the total region were measured. The cortical region was extracted from the total bone region using specific algorithms (separation mode 3 and contour mode 2), and cortical or cancellous BMC and BMD, cortical thickness, periosteal and endosteal circumference (peri. c. and endo. c.), and X-, Y-, and polar-axis strength stain indices (XSSI, YSSI, and PSSI) were measured. The data were processed using XCT Research Series Manual Software Version 5.4 from transverse images of 1 mm of the proximal tibiae.
Analysis of Biochemical Markers in Serum Bone formation was assessed by measuring the amount of the N-terminal middle portion of osteocalcin (N-MID) in serum with an immunoassay kit (Serum Rat-MID Osteocalcin ELISA, Nordicbioscience Diagnostics, Denmark). Bone resorption was evaluated by measuring the serum concentration of the C-terminal telopeptide (Glu-Lys-Ala-His-bAsp-Gly-GlyArg) of the collagen type I a1 chain with an immunoassay kit (Serum RatLap ELISA, Nordicbioscience Diagnostics).
Statistical Analysis A paired two-tailed Student's t-test was used to compare data between two groups and p values of less than 0.05 were treated as statistically significant. All data are expressed as meanϮS.D.
RESULTS AND DISCUSSION
At the end of the experiment, the body weight of rats in the OVX control group increased significantly (by 31.4%) compared with that in the sham-operated group (Fig. 1a) , whereas the uterine weight of rats in the OVX control group significantly decreased (by 74.8%) (Fig. 1b) . Thus the rats were estrogen deficient. The 6-month treatment with E 2 , a common agent in the treatment of osteoporosis in post- menopausal women, as a positive control lowered the body weight (by 24.3% compared with the OVX control group) and restored the uterine weight to the level of sham-operated rats (79% of that in the sham group). Treatment with SST or SST/OHP slightly lowered the body weight (SST1, 6.3%; SST2, 6.5%; SST1/OHP1, 3.3%; SST2/OHP2, 3.8% decrease), compared with the OVX control group. These results indicate that OHP weakly stimulates an increase in body weight. None of the oral intervention groups displayed side affects on uterine weight. Although the mechanism of action of SST and SST/OHP is unclear, the results suggest that they may act in a different manner from estrogen, which affects breast tissue and the uterus as well as bone.
Six months after surgery, OVX reduced BMC and BMD in three regions (total, cancellous, and cortical bone) compared with those in the sham group (Table 2 ). SST2 and SST2/ OHP2 improved the decrease in the BMC of total bone (4.6% and 5.7% improvement, respectively) but not that in the BMD of total bone, leading alterations in bone area as indicated by cortical bone thickness, whereas E 2 treatment inhibited the decreases in BMC and BMD in all three bone types as expected. Although pQCT is used for measuring static bone, the comparison of peri. c., endo. c., and cortical bone thickness among the groups can reflect the actions of OVX and treatment with SST and OHP on cortical bone. The decreasd cortical bone thickness in the OVX control group (sham group, 0.87Ϯ0.07 mm; OVX control group, 0.57Ϯ 0.11 mm) might be induced by high bone turnover, which was the result of a slight increase in bone formation on the periosteal surface (peri. c.: sham group, 12.6Ϯ0.8 mm; OVX control group, 13.0Ϯ0.2 mm) and significant acceleration of bone resorption on the endosteal surface (endo. c.: sham group, 7.12Ϯ0.92 mm; OVX control group, 9.22Ϯ0.86 mm). Both the SST2 and SST2/OHP2 groups showed significant antiresorptive action on the endosteal surface (endo. c.: SST2, 8.71Ϯ0.35 mm; SST2/OHP2, 8.58Ϯ0.49 mm), slight stimulation of bone formation on the periosteal surface (SST2, 13.4Ϯ0.6 mm; SST2/OHP2, 13.5Ϯ0.6 mm), and significant increase in cortical bone thickness (SST2, 0.71Ϯ0.05 mm; SST2/OHP2, 0.71Ϯ0.03 mm). The E 2 group only showed a significant antiresorptive effect on the endosteal surface without action on the periosteal surface. Due to the decreases in BMD and cortical bone thickness, the bone strength of rats in the OVX control group was reduced in the PSSI (11.5% decrease compared with that of the sham group), YSSI (14.9% decrease), and XSSI (10.6% decrease), corresponding to the reduction of the antitwisting (PSSI), antifracture (YSSI), and anticompression (XSSI) bone strengths, respectively. E 2 treatment only improved XSSI markedly due to a slight increase in cortical bone thickness, but SST2 and SST2/OHP2 significantly increased bone area and in turn recovered the bone strength indices decreased by OVX treatment. SST2/OHP2 markedly improved bone strength in all directions (PSSI, 21.1%; YSSI, 8.21%; XSSI, 19.8%), which reflects its potent activity in protecting against bone fracture, the most serious symptom in postmenopausal osteoporosis.
These effects of E 2 , SST, and SST/OHP were also indicated by the levels of biomarkers. Osteocalcin, a peptide of 49 amino acids, is produced by osteoblasts and has a high affinity for calcium. Most (60-90%) of synthesized osteocalcin is incorporated into bone matrix to form new bone, while the remainder is released into the circulation and cleaved into two parts, the 45-49 C-terminus and 1-43/44 N-terminus. The latter peptide (N-MID fragment) is stable in serum and is a more sensitive marker of bone formation than osteocalcin itself.
13) The CTX fragment, a specific epitope of eight amino acids located in the C-terminal telopeptide of collagen type I a1 chain, is generated by normal osteoclastic degradation of bone. A peptide bond of this epitope is susceptible to a spontaneous nonenzymatic reaction resulting in the formation of an isomerized (b-Asp) linkage, which is only found in mature collagen type I of bone matrix. Thus the CTX fragment should be a more exact biomarker of bone resorption than other bone resorption markers.
14)
The serum concentrations of the N-MID fragment and CTX in rats in OVX control groups were higher than those in the sham group (33.9% and 86.0% increase, respectively), indicating an increased bone turnover rate, in which bone resorption was more rapid than bone formation (Fig. 2) . All the orally treated groups showed a slight increase in the concentration of serum N-MID fragment compared with the OVX control group as a result of slight stimulation of bone formation. On the other hand, the concentrations of CTX, especially in the groups treated with SST2 or SST2/OHP2, decreased (SST2, 168.8Ϯ17.0; SST2/OHP2, 172.1Ϯ22.3 ng/ ml; OVX control group, 266.7Ϯ41.6 ng/ml), indicating significant suppression of bone resorption. However, both the concentration of the serum N-MID fragment and CTX in the E 2 group decreased, indicating that E 2 treatment lowered both the increased bone formation and bone resorption induced by OVX.
A comparison of the effects on bone of SST1 and SST1/OHP1 and of SST2 and SST2/OHP2 revealed that the increase in bone mass and bone strength and inhibition of bone resorption were dominantly due to SST, but not OHP. However, OHP slightly increased bone strength and weakly supressed bone resorption, although the effects were not significant.
The rich calcium, protein, amino acids, unsaturated fatty acid, collagen, and vitamins contained in SST may be responsible for its antiosteoporotic activity. Although the same baseline diet was given to OVX control and sham rats, bone mass and bone strengths differed. This may have resulted from the decrease in calcium absorption in the intestine due to the decrease in endoestrogen levels. 15) Multiple placebocontrolled studies demonstrated the importance of adequate calcium intake for both primary and secondary prevention of osteoporosis. 16) Chronic deficiency inevitably leads to skeletal demineralization and enhanced fracture risk. The effects of calcium supplementation are maximized in patients in whom baseline intake is low, especially in the elderly. 17) Premenopausal and menopausal women, as well as middle-aged and elderly men and frail female nursing home residents, respond to calcium supplementation with modest increases in BMD. 18, 19) Those previous studies suggested the importance of routine calcium supplementation. The considerable amounts of ionic and absorbable calcium in SST and its vitamin D 3 content should provide more adequate calcium for deposition on the bone than chemical calcium, resulting in the reduction in fracture risk.
SST contains more than 50% protein and the protein consists of all essential amino acids. SST also contains large quantities of sulfur-containing amino acids, such as methionine, the amino acid most deficient in the Japanese diet, and cystine with stimulative activities on enzymes and liver function. Essential amino acid supplements were reported to increase bone strength through modifications of BMD, trabecular architecture, and cortical thickness. 20) Excess protein may cause a negative calcium balance, whereas low protein intake is associated with fracture due to the associated absorption of calcium. Thus protein intake is important in maintaining bone or minimizing bone loss in elderly persons. 21) Asian women, especially Japanese women, eat rice and soybean as ataples and are offen protein deficient. Thus intermittent uptake of SST would be a good source of protein for the elderly.
A body of epidemiologic, clinical, and experimental evidence suggests that fatty acids have a modulatory effect on bone metabolism in animals and humans. Claassen et al. reported that dietary intake of g-linolenic acid and EPA influenced osteoblast and osteoclast activity in rats, 22) and Kruger and Horrobin suggested animals deficient in essential fatty acids develop severe osteoporosis, coupled with increased renal and arterial calcification. 23) Moreover, supplementation with calcium, g-linolenic acid, and EPA produced a significant reduction in osteocalcin and deoxypyridinoline levels, indicating a decrease in bone turnover. 24) These observations suggest a close link between fatty acids and bone metabolism.
Collagen, the most abundant protein in higher animals, makes up one-third or more of the total body protein of vertebrates, with most of it present in specific body structures, especially in bone. Collagen is essential for the treatment of joint deformity and osteoporosis, in accordance with the saying: "use the bone to tonify the bone." 25) SST contains collagen mainly in the shell. Other nutrients such as vitamin C, vitamin K, magnesium, and potassium are also highly associated with BMD in women. 26) The natural source and combination of many types of absorbable nutrients in SST should make it a good functional supplement for postmenopausal women.
Previous research revealed that SST affects b-adrenoreceptors in rats with induced hyperthyroidism, thus alleviating some symptoms of the thyroid disorder, including osteoporosis. 27) However, which constituents exert this activity are unknown. Thus, further research is necessary to elucidate the detailed mechanism of action of SST. As the strongest natural antioxidant, astaxanthin, the major constituent of OHP, may not act directly on bone, but it may enhance the antioxidant actions of vitamins C and E and prevent oxidation of amino acids and unsaturated fatty acids in the body to stimulate the increase in bone strength by SST. 28) In conclusion, oral administration of SST and SST/OHP three times weekly dose dependently inhibited the bone loss and decrease in bone strength induced by OVX, without effects on the uterus. The effects were considered to be due to slight stimulation of bone formation and strong inhibition of bone resorption based on pQCT measurement and biomarker analysis. The combined usage of SST and OHP showed no synergistic effects, but a slight increase in the effects was observed. These results suggest that SST or SST/OHP would be useful for the prevention and treatment of bone loss and bone fracture due to estrogen deficiency. 
